PetMed Express Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PetMed Express, Inc. (PETS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operating Activities
Net Income-6.27-7.465.1418.7230.6025.8537.74
Depreciation & Amortization7.046.063.552.742.432.262.23
Deferred Income Tax5.250.29-1.63-0.850.31-0.150.13
Stock Based Compensation-6.596.876.624.553.310.000.00
Change in Working Capital3.72-2.7613.92-6.823.307.871.87
Change in Accounts Receivable0.60-1.74-0.040.511.130.000.00
Change in Inventory12.35-6.4213.431.97-16.540.000.00
Change in Accounts Payable-13.466.10-2.29-12.0527.690.000.00
Change in Other Working Capital4.23-0.993.002.478.520.000.00
Other Operating Activities1.570.29-1.63-0.853.443.010.00
Net Cash from Operating Activities4.724.3227.8018.5040.0838.8445.14
Investing Activities
Capital Expenditures-5.11-4.51-5.26-1.752.432.31-0.62
Acquisitions0.00-35.86-5.000.000.000.000.00
Purchases of Investments0.00-0.30-5.000.000.000.000.00
Net Cash from Investing Activities-5.11-40.67-10.26-1.75-2.43-2.31-0.62
Financing Activities
Common Stock Issued0.000.000.000.000.00-11.500.00
Dividends Paid-0.18-12.44-24.54-24.3822.6921.80-21.93
Other Financing Activities0.000.000.000.000.00100.530.00
Net Cash from Financing Activities-0.18-12.44-24.54-24.38-22.69-33.30-21.93
Summary
Net Change in Cash-0.58-48.79-6.99-7.6414.963.2322.59
Cash at Beginning of Period55.30104.09111.08118.72103.76100.5377.94
Cash at End of Period54.7255.30104.09111.08118.72100.53100.53
Free Cash Flow-0.40-0.1922.5416.7537.6436.5344.52
Supplemental Disclosures
Income Taxes Paid0.530.134.316.0910.027.1411.05